Dr Richard McFarlane
- Clinical Lecturer in Advanced Therapy (Cardiovascular & Metabolic Health)
Research interests
Reasearch Theme: Cardiac
Publications
2023
Morrow, Andrew J. 
ORCID: https://orcid.org/0000-0003-4067-8249, McFarlane, Richard and Berry, Colin ORCID: https://orcid.org/0000-0002-4547-8636
(2023)
Novel therapy for ischaemia with no obstructive coronary arteries.
European Heart Journal, 44(30),
pp. 2829-2832.
(doi: 10.1093/eurheartj/ehad391)
(PMID:37377290)
Sykes, Robert ORCID: https://orcid.org/0000-0003-1010-5474 and McFarlane, Richard
(2023)
Icosapent ethyl and plaque regression: insights from the EVAPORATE-FFRCT study.
European Heart Journal: Cardiovascular Imaging, 24(7),
pp. 874-875.
(doi: 10.1093/ehjci/jead086)
(PMID:37119308)
Sykes, R. A. et al. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal: Cardiovascular Pharmacotherapy, 9(4), pp. 371-386. (doi: 10.1093/ehjcvp/pvad025) (PMID:37019821) (PMCID:PMC10236521)
Articles
Morrow, Andrew J. ORCID: https://orcid.org/0000-0003-4067-8249, McFarlane, Richard and Berry, Colin ORCID: https://orcid.org/0000-0002-4547-8636
(2023)
Novel therapy for ischaemia with no obstructive coronary arteries.
European Heart Journal, 44(30),
pp. 2829-2832.
(doi: 10.1093/eurheartj/ehad391)
(PMID:37377290)
Sykes, Robert ORCID: https://orcid.org/0000-0003-1010-5474 and McFarlane, Richard
(2023)
Icosapent ethyl and plaque regression: insights from the EVAPORATE-FFRCT study.
European Heart Journal: Cardiovascular Imaging, 24(7),
pp. 874-875.
(doi: 10.1093/ehjci/jead086)
(PMID:37119308)
Sykes, R. A. et al. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal: Cardiovascular Pharmacotherapy, 9(4), pp. 371-386. (doi: 10.1093/ehjcvp/pvad025) (PMID:37019821) (PMCID:PMC10236521)